Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

JOHNSON & JOHNSON

Johnson & Johnson is a global pharmaceutical, medical devices and consumer packaged goods manufacturer. Founded in 1886, J&J now includes about 250 subsidiaries in more than 57 countries. A household name in the U.S., the company’s products are sold in more than 175 countries. The topic covers Johnson & Johnson the company, its products and market updates.

Johnson & Johnson is part of Business Exchange, suggested by Carlton St Bernard. This topic contains 1,306 news and 1,891 blog items. Read updated news, blogs, and resources about Johnson & Johnson. Find user-submitted articles and reactions on Johnson & Johnson from like-minded professionals.

News

Recent news on this topic.

J.& - J. Unit Phasing Out All-Metal Hip Devicesmore

Johnson & Johnson faces a wave of lawsuits from patients who say they were injured when all-metal implants sold by...

Johnson & Johnson Names New Chairmanmore

Johnson & Johnson said Alex Gorsky, its chief executive, would succeed William C. Weldon, who will step down after...

Bullish on Johnson & Johnsonmore

Stock pierces through recent trading range, signalling higher targets

Johnson & - Johnson to Remove Questionable Chemicals in Productsmore

The announcement extended the company'€™s program to remove certain ingredients from baby products to include adult...

MREB | Tell Me Something I Don’t Know—Why MR is Comprehensive, Accurat...more

While comprehensive and accurate information (the kind Research tends to provide) makes a decision appear “well thought...

MREB | Break the Myopic Focus of Research Requestsmore

Many marketers focus primarily on subjects that are within their span of control—such as features, package, and price.

J&J, Gilead HIV Drug Wins FDA Approvalmore

Johnson & Johnson and Gilead Sciences Inc. won U.S. approval of a once-daily HIV treatment that combines multiple...

Johnson & Johnson to Settle Charge Over Risperdal Marketingmore

An agreement in principle was reached on a misdemeanor criminal charge related to the marketing of the antipsychotic...

Computer Intuition: Financial Analysis Using Psycholinguisticsmore

Conflict of interest fears over vaccine groupmore

Extract not available.

Mo' Mamet, Mo' Mametmore

Since electronic words are cheap, here I present something I really hated to see go from the paper version.

Johnson & Johnson Details Drug Pipeline Advancesmore

Extract not available.

Johnson & Johnson Highlights Strategies For Growth Through Differe...more

/PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) will review growth strategies for its Pharmaceuticals...

Spending spree: the drive for mergers and acquisitionsmore

Extract not available.

Johnson & Johnson To Seek Approval For 11 New Drugs By 2015-Reuter...more

Extract not available.

Video: Talking Numbers: 3 Numbers to Watchmore

Discussing which indicators need to change before jumping back into the markets, with Chris Johnson, Johnson Research...

Stocks vs. Bonds for Income: Let's Rumblemore

During last week's bond blizzard, Johnson & Johnson (NYSE: JNJ With the low bond yield, income investors...

Cancer Research Grows in Chinamore

intent on meeting surging demand for treatments. BeiGene Ltd. hired 20 U.S.-educated scientists from companies...

China���s Cancer Deaths Spur Merck Investment in Beijing Biotechmore

intent on meeting surging demand for treatments. BeiGene Ltd. hired 20 U.S.-educated scientists from companies...

Arthritis Drug���s $1.4 Billion Promise for 4SC Hinges on Studymore

Oaks, California-based Amgen; Humira, from Abbott Park, Illinois-based Abbott Laboratories; and Remicade, sold by New...

JB Chemicals to focus on CRAMS biz after J&J salemore

India's JB Chemicals , which has sold several over-the-counter brands in Russia to Johnson & Johnson , will now...

Johnson & Johnson Stock To Go Ex-dividend Tomorrow (JNJ)more

NEW YORK (TheStreet) -- The ex-dividend date for Johnson & Johnson (NYSE:JNJ) is tomorrow, May 26, 2011.

Johnson & Johnson Arthritis Drug Shows Promise In Mid-Stage Trial-...more

Extract not available.

JB Chemical to sell OTC biz in Russia to JandJ for $260 mnmore

& Pharmaceuticals Ltd (JBCPL) has decided to sell its over-the-counter (OTC) business in Russia and CIS countries...

JNJ Turns a Corner?more

its acquisition of Russia's largest OTC drug business, and future growth, with William Weldon, Chairman & CEO,...

Top Sources: Johnson & Johnson

  • BusinessWeek
  • Financial Times
  • TheStreet.com
  • New York Times
  • Reuters
  • Motley Fool
  • thedeal.com
  • bloomberg.com
  • Wall Street Journal Online
  • MarketWatch

Most Active Users in this Topic

see all contributors in Johnson & Johnson

Featured White Papers

Post a Job

Jobs in this Topic

Registered Nurse Part Time 24 Hours J Labor & Delivery Side A Vidant Medical Center | Greenville, NC
Posted: May 11
Lease Purchase Truck Driver J & R Schugel Trucking | Johnson, NE
Posted: Nov 9
J-1 Psychiatrist Needed in the Hoosier State Locumtenens.com | Indiana
Posted: Jan 23
Lead J2EE Engineer - RS2-j-sf Cybercoders | Oakland, CA
Posted: Apr 21
Hospitalist (Psychiatrist) needed in the Johnson City, TN area Spot On Recruiting | Johnson City, TN
Posted: May 11

Report comment contains invalid characters. ()
cancel
Search Cancel